Congested Nose In Pregnancy __hot__ May 2026

Hormonal changes—specifically elevated estrogen, progesterone, and placental growth hormone—drive increased nasal blood flow, glandular hypersecretion, and mucosal edema. While benign for most, severe congestion can impair sleep, cause snoring, and exacerbate obstructive sleep apnea (OSA), which is linked to gestational hypertension and fetal growth restriction. First-line management includes non-pharmacological measures (humidifiers, nasal saline irrigation, sleep position elevation). Intranasal corticosteroids (e.g., budesonide, fluticasone) are considered safe and effective for moderate-to-severe symptoms. Decongestants, particularly oral pseudoephedrine, are relatively contraindicated in the first trimester due to a possible association with gastroschisis, and intranasal oxymetazoline should be limited to short-term use (≤3 days) due to rhinitis medicamentosa.

This review aims to synthesize current evidence on the pathophysiology, maternal and fetal implications, and evidence-based management strategies for pregnancy-related nasal congestion. congested nose in pregnancy

A narrative review of peer-reviewed literature from PubMed, Cochrane Library, and clinical practice guidelines (2010–2025) was conducted. Intranasal corticosteroids (e

Pregnancy-Related Rhinitis: Etiology, Clinical Impact, and Management of Nasal Congestion in Gestation Authors (Example) [Your Name], M.D.; [Co-author Name], Ph.D. Department of Obstetrics and Gynecology / Otorhinolaryngology [Institution Name] Abstract Background: Nasal congestion is a common but often underappreciated symptom during pregnancy, affecting an estimated 20-40% of gravid individuals. Termed "pregnancy rhinitis," this condition is defined as nasal congestion lasting six or more weeks during gestation, in the absence of other identifiable allergic or infectious causes. A narrative review of peer-reviewed literature from PubMed,

Pregnancy rhinitis significantly impacts quality of life and sleep. A stepwise, evidence-based approach prioritizing non-pharmacological and topical therapies is recommended. Further prospective research on long-term maternal-fetal outcomes is warranted.